Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies

NCT03157154 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT03157154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03157154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Completed
Start date
June 27, 2017
Completion date
July 30, 2017
Enrollment
259 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia